By Boston Real Estate Times -February 19, 2021 CHICAGO— Capri EGM, an investment company specializing in corporate build-to-suit and sale leaseback financing, and the acquisition of income generating logistics, life science, and R&D corporate real estate, announced that it has entered into an agreement to sell the Sanofi Genzyme Global Distribution Facility, one of its life science […]

Capri EGM Sells Sanofi Genzyme Global Distribution Facility, Maintains its Life Science, R&D, and Logistics Investment Conviction CHICAGO, Feb. 18, 2021 /PRNewswire/ — Capri EGM, an investment company specializing in corporate build-to-suit and sale leaseback financing, and the acquisition of income generating logistics, life science, and R&D corporate real estate, announced today that it has entered into an […]

By Lupe ReyesCoStar Research February 22, 2021 | 1:08 P.M. Capri EGM, a Chicago-based investment company that focuses on net lease, sale-leaseback and build-to-suit transactions, has agreed to sell a life science distribution facility leased to Sanofi Genzyme for $33 million. (Read the full article at CoStar)